Kuros Biosciences Financial Overview
Kuros Biosciences's market cap is currently $1.38B. The company's EPS TTM is $-0.06592794; its P/E ratio is -188.04; Kuros Biosciences is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.
